Herbal formula Danggui-Shaoyao-San promotes neurogenesis and angiogenesis in rat following middle cerebral artery occlusion

Changhong Ren, Brian Wang, Ning Li, Kunlin Jin, Xunming Ji

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Current studies demonstrated that traditional Chinese herbal formula Danggui-Shaoyao-San (DSS) is not only used for the treatment of menstrual disorder, but has also found its use in neurological diseases. However, the neuroprotective role of DSS on ischemia-induced brain injury is still unclear. The aim of the present study is to explore the effect of DSS in ischemic brain injury. Total 30 adult female Sprague-Dawley rats underwent 90 min transient middle cerebral artery occlusion (MCAO). DSS (600 mg/kg) was administered through the intragastric route at the time of reperfusion and then performed every day thereafter until sacrifice. Results showed that DSS treatment significantly improved neurobehavioral outcomes (N=10 per group, P < 0.05). Immunohistochemical staining showed that microvessel density in the perifocal region of DSS-treated rats was significantly increased compared to the saline-treated group (N=4 per group, P < 0.01). Similarly, the numbers of BrdU+/DCX+ cells in the subventricular zone were increased in DSS-treated rats compared to the saline-treated group (P < 0.05). Furthermore, we demonstrated that DSS treatment activated vascular endothelial growth factor (N=4 per group,P < 0.05) and promoted eNOS phosphorylation (N=4 per group, P < 0.05). Thus, we concluded that DSS promoted focal angiogenesis and neurogenesis, and attenuated ischemia-induced brain injury in rats after MCAO, suggesting that DSS is a potential drug for ischemic stroke therapy.

Original languageEnglish
Pages (from-to)245-253
Number of pages9
JournalAging and Disease
Volume6
Issue number4
DOIs
StatePublished - 1 Jan 2015

Fingerprint

Middle Cerebral Artery Infarction
Neurogenesis
Brain Injuries
Ischemia
danggui-shaoyao-san
Lateral Ventricles
Bromodeoxyuridine
Microvessels
Vascular Endothelial Growth Factor A
Reperfusion
Sprague Dawley Rats
Stroke
Phosphorylation
Staining and Labeling

Keywords

  • Angiogenesis
  • Dangui-Shaoyao-San
  • Ischemic stroke
  • Neurogenesis

Cite this

@article{c6215359b1f84bd29bd083184c40ce9d,
title = "Herbal formula Danggui-Shaoyao-San promotes neurogenesis and angiogenesis in rat following middle cerebral artery occlusion",
abstract = "Current studies demonstrated that traditional Chinese herbal formula Danggui-Shaoyao-San (DSS) is not only used for the treatment of menstrual disorder, but has also found its use in neurological diseases. However, the neuroprotective role of DSS on ischemia-induced brain injury is still unclear. The aim of the present study is to explore the effect of DSS in ischemic brain injury. Total 30 adult female Sprague-Dawley rats underwent 90 min transient middle cerebral artery occlusion (MCAO). DSS (600 mg/kg) was administered through the intragastric route at the time of reperfusion and then performed every day thereafter until sacrifice. Results showed that DSS treatment significantly improved neurobehavioral outcomes (N=10 per group, P < 0.05). Immunohistochemical staining showed that microvessel density in the perifocal region of DSS-treated rats was significantly increased compared to the saline-treated group (N=4 per group, P < 0.01). Similarly, the numbers of BrdU+/DCX+ cells in the subventricular zone were increased in DSS-treated rats compared to the saline-treated group (P < 0.05). Furthermore, we demonstrated that DSS treatment activated vascular endothelial growth factor (N=4 per group,P < 0.05) and promoted eNOS phosphorylation (N=4 per group, P < 0.05). Thus, we concluded that DSS promoted focal angiogenesis and neurogenesis, and attenuated ischemia-induced brain injury in rats after MCAO, suggesting that DSS is a potential drug for ischemic stroke therapy.",
keywords = "Angiogenesis, Dangui-Shaoyao-San, Ischemic stroke, Neurogenesis",
author = "Changhong Ren and Brian Wang and Ning Li and Kunlin Jin and Xunming Ji",
year = "2015",
month = "1",
day = "1",
doi = "10.14336/AD.2014.1126",
language = "English",
volume = "6",
pages = "245--253",
journal = "Aging and Disease",
issn = "2152-5250",
publisher = "International Society on Aging and Disease",
number = "4",

}

Herbal formula Danggui-Shaoyao-San promotes neurogenesis and angiogenesis in rat following middle cerebral artery occlusion. / Ren, Changhong; Wang, Brian; Li, Ning; Jin, Kunlin; Ji, Xunming.

In: Aging and Disease, Vol. 6, No. 4, 01.01.2015, p. 245-253.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Herbal formula Danggui-Shaoyao-San promotes neurogenesis and angiogenesis in rat following middle cerebral artery occlusion

AU - Ren, Changhong

AU - Wang, Brian

AU - Li, Ning

AU - Jin, Kunlin

AU - Ji, Xunming

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Current studies demonstrated that traditional Chinese herbal formula Danggui-Shaoyao-San (DSS) is not only used for the treatment of menstrual disorder, but has also found its use in neurological diseases. However, the neuroprotective role of DSS on ischemia-induced brain injury is still unclear. The aim of the present study is to explore the effect of DSS in ischemic brain injury. Total 30 adult female Sprague-Dawley rats underwent 90 min transient middle cerebral artery occlusion (MCAO). DSS (600 mg/kg) was administered through the intragastric route at the time of reperfusion and then performed every day thereafter until sacrifice. Results showed that DSS treatment significantly improved neurobehavioral outcomes (N=10 per group, P < 0.05). Immunohistochemical staining showed that microvessel density in the perifocal region of DSS-treated rats was significantly increased compared to the saline-treated group (N=4 per group, P < 0.01). Similarly, the numbers of BrdU+/DCX+ cells in the subventricular zone were increased in DSS-treated rats compared to the saline-treated group (P < 0.05). Furthermore, we demonstrated that DSS treatment activated vascular endothelial growth factor (N=4 per group,P < 0.05) and promoted eNOS phosphorylation (N=4 per group, P < 0.05). Thus, we concluded that DSS promoted focal angiogenesis and neurogenesis, and attenuated ischemia-induced brain injury in rats after MCAO, suggesting that DSS is a potential drug for ischemic stroke therapy.

AB - Current studies demonstrated that traditional Chinese herbal formula Danggui-Shaoyao-San (DSS) is not only used for the treatment of menstrual disorder, but has also found its use in neurological diseases. However, the neuroprotective role of DSS on ischemia-induced brain injury is still unclear. The aim of the present study is to explore the effect of DSS in ischemic brain injury. Total 30 adult female Sprague-Dawley rats underwent 90 min transient middle cerebral artery occlusion (MCAO). DSS (600 mg/kg) was administered through the intragastric route at the time of reperfusion and then performed every day thereafter until sacrifice. Results showed that DSS treatment significantly improved neurobehavioral outcomes (N=10 per group, P < 0.05). Immunohistochemical staining showed that microvessel density in the perifocal region of DSS-treated rats was significantly increased compared to the saline-treated group (N=4 per group, P < 0.01). Similarly, the numbers of BrdU+/DCX+ cells in the subventricular zone were increased in DSS-treated rats compared to the saline-treated group (P < 0.05). Furthermore, we demonstrated that DSS treatment activated vascular endothelial growth factor (N=4 per group,P < 0.05) and promoted eNOS phosphorylation (N=4 per group, P < 0.05). Thus, we concluded that DSS promoted focal angiogenesis and neurogenesis, and attenuated ischemia-induced brain injury in rats after MCAO, suggesting that DSS is a potential drug for ischemic stroke therapy.

KW - Angiogenesis

KW - Dangui-Shaoyao-San

KW - Ischemic stroke

KW - Neurogenesis

UR - http://www.scopus.com/inward/record.url?scp=84937948808&partnerID=8YFLogxK

U2 - 10.14336/AD.2014.1126

DO - 10.14336/AD.2014.1126

M3 - Article

AN - SCOPUS:84937948808

VL - 6

SP - 245

EP - 253

JO - Aging and Disease

JF - Aging and Disease

SN - 2152-5250

IS - 4

ER -